secwatch.observer — SEC 8-K summary
======================================

Issuer:     Beam Therapeutics Inc. (BEAM)
CIK:        0001745999
Form:       8-K
Filed at:   2025-06-06T23:59:59+00:00
Accession:  0000950170-25-083043
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Beam Therapeutics shareholders elect directors, ratify Deloitte, approve say-on-pay
--------------------------------------------------------------------------------

- Elected Mark Fishman (61.9M for, 10.3M against), Carole Ho (71.7M for), and Kathleen Walsh (71.9M for) as Class II directors.
- Ratified Deloitte & Touche as independent auditor for FY2025 with 84.3M for, 154K against, 63.6K abstentions.
- Advisory vote on named executive officer compensation approved: 71.7M for, 562.9K against, 33.9K abstentions.
- All proposals passed; broker non-votes were 12.2M on director elections and say-on-pay.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1745999/000095017025083043/0000950170-25-083043-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1745999/000095017025083043/beam-20250604.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-083043

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer